LTS Lohmann Therapy Systems Corporation Sustainability Profile
LTS Lohmann Therapy Systems Corporation, commonly referred to as LTS, is a leading player in the medical device industry, headquartered in the United States. Founded in 1989, the company has established a strong presence in key operational regions, including Europe and Asia, focusing on innovative therapeutic solutions. LTS is renowned for its advanced transdermal drug delivery systems, which are designed to enhance patient compliance and optimise therapeutic outcomes. Their unique approach combines cutting-edge technology with a commitment to quality, setting them apart in a competitive market. With a reputation for excellence, LTS has achieved significant milestones, including numerous industry certifications and partnerships that underscore its market position. The company continues to drive innovation, making it a trusted name in the field of medical therapies.
DitchCarbon Score
How does LTS Lohmann Therapy Systems Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
LTS Lohmann Therapy Systems Corporation's score of 43 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
LTS Lohmann Therapy Systems Corporation's reported carbon emissions
LTS Lohmann Therapy Systems Corporation, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of LTS Lohmann Therapie-Systeme AG, which may influence its climate commitments and reporting practices. As of now, LTS Lohmann Therapy Systems Corporation has not established any documented reduction targets or climate pledges. The absence of specific initiatives or targets suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the lack of emissions data and reduction commitments, it is essential for LTS Lohmann Therapy Systems Corporation to consider aligning with industry standards and best practices in climate action. This could involve setting science-based targets and participating in initiatives such as the Science Based Targets initiative (SBTi) to enhance its sustainability profile and contribute to global climate goals.
How Carbon Intensive is LTS Lohmann Therapy Systems Corporation's Industry?
How Carbon Intensive is LTS Lohmann Therapy Systems Corporation's Location?
LTS Lohmann Therapy Systems Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
LTS Lohmann Therapy Systems Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
